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Visual sensitivityThere are pieces of evidence indicating that visual deﬁcits in patients with schizophrenia can be attrib-
uted to a deﬁciency in the magnocellular portion of the early visual system. The main objective of this
study was to investigate the neurological dysfunction of the magnocellular pathway in patients with
schizophrenia using the frequency doubling technology perimetry (FDT). The FDT has been developed
based on particular neural magnocellular characteristics and can examine the magnocellular dysfunction
hypothesis in schizophrenia. Twenty patients with schizophrenia (12 males and 8 females) and 20 nor-
mal subjects (10 males and 10 females) participated in this study. The spatial frequency doubling task
was presented via the Humphrey perimetry instrument in order to examine the magnocellular pathway
of the participants. Patients with schizophrenia showed less visual ﬁeld sensitivity than normal controls
and their standardized age cohort in both eyes (p < 0.001). The results indicated impaired visual ﬁeld sen-
sitivity deﬁcits in patients with schizophrenia that can be attributed to a deﬁcit in the magnocellular neu-
ral pathways. This Magnocellular pathway defect may provide a physiological base to explain some of the
deﬁcits caused by schizophrenia such as cognitive deﬁcits.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Visual processing deﬁcits in schizophrenia have long been con-
sidered by researchers. Earlier research had shown that patients
with schizophrenia have deﬁcits in visual integration and normal
backward masking (Saccuzzo & Braff, 1981). More recent research
indicated reduced contrast sensitivity (Butler & Javitt, 2005), re-
duced visual ERP amplitudes (ERPs), increased thresholds for eval-
uation of visual stimuli (Butler et al., 2005; Slaghuis, 1998),
reduced neurophysiologic response to a single stimulus (Butler
et al., 2001), deﬁcits in motion processing (e.g. Chen et al., 2004),
and deﬁcits in spatial–temporal integration (Makarem et al.,
2010) in patients with schizophrenia. The relation between these
deﬁcits is not well understood.
Some researchers have proposed that a portion of these visual
processing deﬁcits might be attributed to a potential malfunction
of the magnocellular pathway in patients with schizophrenia
(e.g., Kim et al., 2006; Martinez et al., 2008; Schechter et al., 2003).
The visual pathway consists of three main streams: Magnocel-
lular, Parvocellular, and Koniocellular. The Magnocellular stream
(M cells) is responsible for transferring low spatial frequency and
high temporal frequency information, i.e. it is responsible for vision
in low light and seeing moving objects. The Parvocellular pathway
(P cells) is responsible for transferring high spatial frequency and
low temporal frequency information, i.e. it is responsible fordetailed vision and seeing static objects. The Koniocellular
pathway (K cells) is responsible for transferring short or blue
wavelength (Mashayekhy et al., 2008). It is expected that magno-
cellular deﬁcits emerge at low spatial frequencies (e.g. 1.5 c/deg)
and high temporal frequencies (Skottun & Skoyles, 2007a).
Research have shown that the magnocellular pathway transfers
information related to movement, stereopsis, spatial localization,
depth perception, hyperacuity, ﬁgural grouping, illusory border
perception, and ﬁgure/ground separation (Livingstone, 1987; as ci-
ted in Patel, 2004).
A magnocellular pathway dysfunction has been reported by
several investigators in patients with schizophrenia using different
techniques. Martinez et al. (2008) reported a reduced activity to
low spatial frequencies (but not high spatial frequencies) in several
areas of the parietal and temporal lobes using functional magnetic
resonance imaging. Kim et al. (2006) showed that deﬁcits in mo-
tion processing in schizophrenia are signiﬁcantly associated with
reduced activity of the magnocellular vision systems using steady
state Visual Evoked Potentials (ssVEP). Schechter et al. (2003)
showed a signiﬁcant functional impairment in schizophrenic pa-
tients’ magnocellular pathways using a backward masking task.
It has also been observed that patients with schizophrenia have re-
duced electrophysiological activity for magnocellular oriented
stimuli (Butler et al., 2001).
Another effective and reliable way to separate magnocellular
activities in psychosomatic tests is the measurement of contrast
sensitivity (Skottun & Skoyles, 2007a). Studies on injuries to differ-
ent layers of Lateral Geniculate Nucleus (LGN) of monkeys found
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lular layers is limited to cases where stimuli are of low spatial fre-
quency or high temporal frequency (Merigan, Byrne, & Maunsell,
1991a; Merigan, Katz, & Maunsell, 1991b; Merigan & Maunsell,
1990, 1993; Schiller, Logothetis, & Charles, 1990a, 1990b; as cited
in Skottun & Skoyles, 2007a). Psychosomatic studies on humans
are consistent with these ﬁndings (Legge, 1978, Tolhurst, 1975;
as cited in Skottun & Skoyles, 2007a).
Several studies have reported signiﬁcant differences between
patients with schizophrenia and the control groups in different
spatial contrast sensitivity tasks indicative of magnocellular inefﬁ-
ciency (e.g., Butler et al., 2005; Keri et al., 2002; O’Donnel et al.,
2006; Revheim et al., 2006; Schwartz, McGinn, & Winstead,
1987; Slaghuis, 1998, 2004; Slaghuis & Bishop, 2001; Slaghuis &
Thompson, 2003).
Some studies investigated spatial and temporal frequencies via
a combined method. In a study by Keri et al. (2005), a spatial origin
task was used. The results of this study showed that, like their bio-
logical relatives, patients with schizophrenia – under both medica-
tion and non-medication – have more deﬁnitive deﬁcits
in situations of low contrast and doubled frequency compared to
consistent lighting. These ﬁndings support the magnocellular def-
icits in schizophrenia, because low contrast and doubled frequency
are likely indicators of magnocellular inefﬁciency. Chen et al.
(2004) showed varying degrees of reduced sensitivity for part of
subjects with schizophrenia. In contrast, Keri et al. (2000),
Gutherie, McDowell, and Hammond (2006) and Delord et al.
(2006), found no deﬁcits related to magnocellular malfunction in
patients with schizophrenia.
Research conducted to date has investigated the magnocellular
deﬁcits in schizophrenia and other disorders using different tasks.
Each of these tasks considers a speciﬁc deﬁcit in schizophrenia (e.g.
backward masking, motion processing, contrast sensitivity, etc.) or
measures low spatial frequencies or high temporal frequencies
which are features of the magnocellular pathway. There are many
disputes about the reliability and validity of these instruments.
Although the results of these studies, are consistent with the mag-
nocellular system malfunction in schizophrenia disorder, some
other studies tend to disprove them (e.g. Barch et al., 2003; Braus
et al., 2002; Delord et al., 2006; Gutherie, McDowell, & Hammond,
2006; Selemon & Begovic, 2007; Skottun & Skoyles, 2007a, 2007b;
Slaghuis & Bishop, 2001). There are substantial controversies over
research methods and it seems that a measurement instrument is
required that speciﬁcally focuses on features unique to the magno-
cellular pathway and which evaluates its function validly and
reliably.
Kelly (1966; as cited in Patel, 2004) introduced a phenomenon
named the doubled frequency illusion. In this frequency-doubling
task the stimuli include alternating black and white stripes with
low spatial frequency (0.25 c/deg). The place of these white and
black stripes changes alternatively with high temporal frequency
(25 Hz) creating a ﬂickering appearance. In this situation, the num-
ber of black and white stripes appears to be doubled.
In the 1990s, this phenomenon was linked to a subset of type M
(Magnocellular) cells that could selectively become damaged in
glaucoma. Since thenmany researchers have studied this phenome-
non (Maddess & Henry, 1992; Quigley et al., 1987; Johnson, 1994;
Johnson & Samuel, 1997; Maddess et al., 1999; Maddess & Severt,
1999; Kalaboukhova & Lindblom, 2003, all cited in Patel, 2004). It
is believed that the perception of this low spatial frequency sinusoi-
dal gratingwithhighﬂickering temporal frequencyoccursdue to the
non-linear magnocellular mechanisms (Johnson & Demirel, 1997).
The Humphrey Matrix is the latest perimetry generation of fre-
quency doubling technology (FDT) which was developed in 2003
with seven functional tests for the eye care professions (Patel,
2004). It is considered as a detailed, fully equipped and reliablevisual ﬁeld testing instrument that evaluates the magnocellular
pathway directly taking into account its special features. Doubled
frequency perimetry provides a contrast sensitivity test for detect-
ing magnocellular pathway deﬁcit (Anderson & Johnson, 2003).
Many studies have shown that doubled frequency perimetry can
detect impairments in the visual ﬁeld that are overlooked by other
methods (Dublin, 2003). The Humphrey Matrix has high differen-
tial ability in detecting early functional damage in patients at risk
(Spry et al., 2005; as cited in Zeppieri & Johnson, 2008). Various
studies have provided promising results using the Humphrey Ma-
trix which is the result of its precision, accuracy, sensitivity, spec-
iﬁcity, and reliability (Johnson et al., 1999; Turpine et al., 2003;
Arts et al., 2005; Anderson & Johnson, 2005; all cited in Zeppieri
& Johnson, 2008).
The FDT visual ﬁeld instrument selectively examines the mag-
nocellular visual pathway (Patel, 2004), but has not previously
been used to investigate visual function in schizophrenia. This
study utilizes doubling frequency technology to test the magnocel-
lular deﬁcit hypothesis in patients with schizophrenia.2. Materials and methods
2.1. Design
The research method for this study was causal–comparative.
The independent variable was schizophrenia (belonging to the
group) and the dependent variable was Magnocellular deﬁcit mea-
sured through evaluation of visual ﬁeld sensitivity by means of
Humphrey perimetry frequency doubling technology.2.2. Subjects
The experimental group included all non-hospitalized patients
with schizophrenia who referred to Hafez Hospital, Shiraz. The
control group included eye clinic staff and patients’ companions.
The sample included 20 patients (12 males and 8 females) and
20 healthy persons (10 males and 10 females) as control group.
Inclusion criteria for the experimental group (selected via conve-
nience sampling method) restricted to patients in the 18–50 years
old age range, with normal vision (20/20 as tested by Snellen
chart), and with a diagnosis of acute schizophrenia, as diagnosed
by a psychiatrist based on clinical interview. The patients were se-
lected based on DSM-IV-TR diagnostic criteria. The exclusion crite-
ria included physical and mental illnesses apart from the main
diagnosis (such as drug abuse, mental retardation or having a se-
vere emotional disturbance). The control group participants were
selected via convenience sampling method. The exclusion criteria
for this group included any psychiatric diagnosis or history of psy-
chiatric diagnosis, neurological illness, head injury, accident or
medical eye disorders. A review of these variables was accompa-
nied by participants’ or their companions’ reports.
Patients, who referred to Department of Psychiatry in Hafez
Hospital and had schizophrenia diagnosis, were referred to the re-
searcher by the psychiatrist. After interviewing each patient and
ensuring that they met the criteria of schizophrenia and other
inclusion criteria, the researcher explained the perimetry test and
its duration and the purpose of research. The patients were told
that the test was performed in the eye ward of Shiraz Motahari
Clinic. The patients who agreed with all of these conditions signed
‘‘the informed consent form to participate in research project’’ that
included the name of the research project, and the related school
and executives, conﬁdentiality issues, beneﬁts, the right to reject
or cancel, and response to all questions. Any expenses including
patients’ travelling and testing costs were incurred by the re-
searcher. Both of the patient’s eyes were tested using the
Table 1
Demographic characteristics (age and gender) of groups.
Groups n Man Woman Age range Mean SD
Schizophrenia 20 12 8 19–45 28.25 7.77
Normal’s 20 10 10 20–40 30.25 6.18
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room by trained personnel. All patients were on different doses
of antipsychotic medication.
2.3. Materials and stimuli
2.3.1. Frequency doubling Humphrey Matrix
The Humphrey Matrix is the latest generation of perimetry fre-
quency doubling technology. It (30 cm  56 cm  43 cm, 14 kg) in-
cludes a liquid crystal menu display screen, a video eye monitor, a
patient visor, and a patient response button as well as separate full
keyboard with a track pad and an external printer and internal
software. The Humphrey Matrix has many advantages, such as
ease of application and interpretation of results. Moreover, it is
not affected by cataract and refractive errors (large stimuli elimi-
nate the need for trial lens correction) and it has rapid test meth-
ods (less than 5 min per eye). The test has high test–retest
reliability (Zeppieri & Johnson, 2008). Another important advan-
tage is that the test can be scheduled and automated to prevent
any possible changes on the part of the examiner (Riordan-Eva,
Vaughan, & Asbury, 2003).
2.3.2. Stimulus
The 24–2 test that was used in this study is one of the seven
tests of the Humphrey Matrix which uses 5 square stimuli that
are presented at random order with counter-phase ﬂickering
method with temporal frequency of 18 Hz and spatial frequency
of 0.5 c/deg and tests 55 locations. Quantitative measurements of
the visual ﬁeld in each location of Humphrey Matrix tests are com-
pared to a database normalized with more than 270 people
(18–85 years). In fact, in this type of test, doubled frequency sinu-
soidal stimuli which included black and white stripes quickly
replacing each other in a small square, are shown for 300 ms
(per stimulus) in different parts of the visual ﬁeld. The mean test
background illumination was set at 100 cd/m. Contrast ranges var-
ied from 38 dB to 0 dB. The subject was supposed to rest his or her
forehead on the visor without the assistance of a chin rest and
every time saw one of the stimulus, push a button that was located
in his or her hand so that the system would record his/her answers.
2.3.3. Researcher-made questionnaire
The other research instrument was a self-report questionnaire
developed by the researcher which measured age, sex, and other
variables such as time since which treatment has begun and life-
time history of any physical or mental illnesses.Table 2
Mean and SDs of visual ﬁeld sensitivity for both eyes by groups.
Subjects Right eye Left eye
Schizophrenia (n = 20) 8.15 (6.21) 5.06 (4.87)
Normal’s (n = 20) 1.32 (1.56) 1.54 (1.68)
Table 3






t-test for equality of means




Right 26.55 0.001 6.615 21.407 9.47 0.001
Left 10.78 0.002 5.729 23.481 6.61 0.0013. Results
Among 20 cases of schizophrenic patients in this study, one pa-
tient had no history of hospitalization. Other patients had between
1 and 6 incidences of psychiatric hospitalization. Two patients had
no history of receiving ECT and others received ECT 1–22 times.
Three of these patients were of type II and type I schizophrenia
and the rest had been receiving treatment since 8 months to
21 years before. At the time of study none were hospitalized, but
all were taking antipsychotic medications. The average number
of hospitalizations for patients in general was 7 times and the aver-
age amount of time patients were under psychiatrists’ supervisions
was 82 months. Demographic characteristics of groups have been
presented in Table 1.
Although, the two groups were not equal in terms of gender due
to the low number of female patients with schizophrenia, Fisher
exact test showed that the two groups were not statistically differ-
ent in terms of gender. This coefﬁcient was equal to 0.75 (df = 1,
p > 0.05). Independent samples t-test indicated that the groupsdid not differ signiﬁcantly in terms of education (t = 1.159,
df = 38, p > 0.05) and age (t = 0.90, df = 38, p > 0.05).
FDT provides a mean deviation (MD) index to generally summa-
rize the visual ﬁeld results for threshold tests. MD represents the
average sensitivity deviation from a normal healthy person of the
same age (based on the normative data base). The MD is an indica-
tion of the overall visual ﬁeld sensitivity, and can either be a neg-
ative or positive value depending on if the individual’s general
contrast sensitivity is below or above the average for that same
age group. A defective visual ﬁeld is presented by a negative value.
MD is relatively insensitive to localized defects and is strongly af-
fected by generalized trends and thus negative MDs are an indica-
tion of abnormal magnocellular visual pathway (Zeppieri &
Johnson, 2008). Table 2 shows the mean and standard deviation
of MD scores for groups in left and right eyes.
In order to examine whether patients with schizophrenia and
normal controls demonstrated different visual ﬁeld sensitivity in
the right and left eyes, the mean deviation scores were subjected
to a 2  2 repeated measures ANOVAS with group (schizophrenia
and normals) as between subject factor and the eyes (left and
right) as within subject factor. The main effects were signiﬁcant:
group [df = (38,1), F = 50.1, p < 0.001], eyes [df = (38,1), F = 4.89,
p < 0.03]. However, the group  eyes interaction was not signiﬁ-
cant [df = (38, 1), F = 3.45, p < 0.07]. Overall, the results show that
patients with schizophrenia have less visual ﬁeld sensitivity than
normal controls in both eyes. In addition, irrespective of group, to-
tal visual ﬁeld sensitivity is less in the right eye (M = 1.92,
SE = .57) than the left eye (M = 3.31, SE = .73). Independent t-tests
for each eye showed a signiﬁcant difference between the two
groups in both eyes (see Table 3).
FDT provides three reliability indices to verify whether or not
test results are valid. The reliability indices check for ﬁxation errors
in addition to false negative and false positive errors. If one of these
values had gone out of 20%, the system was stopped and the exper-
imenter repeated the test. Table 4 shows these indices (the ratio of
errors) for patients with schizophrenia and normal controls in left
and right eyes. These data shows that the averages of errors are
about .05% or 5%.
Table 5
Repeated measures ANOVA for Group  Errors  Eyes.
Source of variance
df f p
Group 1,38 1.24 .27
Eyes 1,38 .15 .70
Group  Eyes 1,38 3.34 .08
Errors 1,38 .09 .76
Group  Errors 1,38 .16 .69
Errors  Eyes 1,38 .03 .87
Group  Errors  Eyes 1,38 .20 .66
Groups: patients with schizophrenia and normal’s; eyes: left and right; errors:
ﬁxation errors, false positive errors and false positive errors.
Table 4
Mean and SDs of the ratio of errors for both eyes in groups.
Subjects Errors Right eye Left eye
M SD M SD
Schizophrenia (n = 20) Fixation .09 0.13 .06 .09
False positive .03 .05 .02 .05
False negative .08 .08 .06 .10
Normals (n = 20) Fixation .03 .05 .05 .06
False positive .04 .05 .05 .07
False negative .04 .09 .05 .08
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sures ANOVAS with group (schizophrenia and normals) as between
subject factor and eyes (left and right) and errors (ﬁxation errors,
false positive errors and false negative errors) as within subject
factors. None of the main effects and interactions was signiﬁcant
(Table 5). This indicates that the errors were not signiﬁcantly dif-
ferent in both groups and both eyes.4. Discussion
This study was designed to examine the extent of magno-deﬁct
involvement in schizophrenia using the frequency doubling tech-
nology. Frequency doubling technology has been used in several
studies not related to schizophrenia to determine magnocellular
pathway deﬁciencies (Patel, 2004). The results from current study
provide support for a magno deﬁcit in schizophrenia. Patients with
schizophrenia showed less sensitivity to the frequency doubling
stimuli compared to the normal group as well as a signiﬁcant de-
crease in sensitivity compared to their standardized age cohort
(except for one patient, the rest of patients showed a negative
score in Humphrey’s test, indicative of a deﬁcit in magnocellular
pathway). This deviation was not apparent with the normal group
who demonstrated sensitivity comparable to their age group.
This result is consistentwith the ﬁndings of several other studies
which used contrast sensitivity to detect magnocellular deﬁciency
in patients with schizophrenia (see Skottun & Skoyles, 2007a for a
review). As mentioned earlier, the effect of doubled frequency cre-
ated by a low spatial frequency combined with a high temporal fre-
quency is essential for preferential stimulation of magnocellular
cells with a good technique. In fact, the values of contrast sensitivity
for doubled frequency stimuli are more effective in detecting mag-
nocellular deﬁcits than when each spatial or temporal frequency is
presented separately (Johnson & Demirel, 1997).
The result of the current study is consistent with the results of
several other studies indicative of abnormality in low-level sensory
processing (e.g. Butler et al., 2005; Slaghuis, 2004), motion track-
ing, trajectory and spatial localization (O’Donnel et al., 1996 as ci-
ted in Martinez et al., 2008; Chen et al., 1999, 2003, 2004; Lee,2002; Brenner et al., 2003; Keri et al., 2004; Steve et al., 1997; all
cited in Butler et al., 2005), electrophysiological recordings of ERPs
(Butler et al., 2007; Schechter et al., 2005), electrophysiological
activity of Magnocellular oriented stimuli (Butler et al., 2001; as ci-
ted in Schechter et al., 2003), visual integration, and backward
masking (Saccuzzo & Braff, 1981) in patients with schizophrenia.
The result of this study is also consistent with the results of sev-
eral other studies on spatial frequency (Keri et al., 2002; Slaghuis,
1998, 2004; Slaghuis & Thompson, 2003), temporal frequency
(Chen et al., 2003; Laycock, Crewther, & Crewther, 2007; O’Donnel
et al., 2006; Schwartz, McGinn, & Winstead, 1987; Slaghuis &
Bishop, 2001), and combining both temporal and spatial frequen-
cies (Chen et al., 2004; Cimmer et al., 2006; Delord et al., 2006;
Gutherie, McDowell, & Hammond, 2006; Keri, 2008; Keri et al.,
2005) in patients with schizophrenia.
Skottun and Skoyles (2007a) in a research review on contrast
sensitivity and magnocellular functioning in schizophrenia came
to the conclusion that the studies on contrast sensitivity in patients
with schizophrenia provide little evidence for a magnocellular def-
icit. They attributed contrast sensitivity reductions in patients with
schizophrenia to attentional problems. They also declared that
attention deﬁcit is probably unrelated to vision; as such problems
can arise out of ﬂawed performance of pre-frontal cortex (Skottun
& Skoyles, 2007a). Although the result of this study cannot reject
the above conclusion completely and attentional problems might
exert some effect on the response of patients, the task checks for
attentional distractions viamonitoring ﬁxations error, false positive
and false negative errors. The analysis of reliability indices showed
that the test results are valid when we consider ﬁxation, false posi-
tive and false negative errors. In addition, the selective impairment
of the magnocellular system in glaucoma and the ability of fre-
quency doubling technology to illustrate these impairments have
been previously well documented (Maddess et al., 1999).
Butler et al. (2001), Keri et al. (2002), and Butler et al. (2005)
postulate that early stage visual processing deﬁcits signiﬁcantly
predict higher level cognitive impairments. Martinez et al. (2008)
showed that the sensory processing deﬁcits can be related to high
levels of cognitive impairment, active memory, executive function
and attention. Therefore, it is possible that magnocellular deﬁcits
in patients with schizophrenia can affect higher cognitive systems.
Recent studies that suggest visual processing deﬁcits in schizo-
phrenia, especially in tasks such as motion tracking, trajectory
and spatial localization (Chen et al., 1999, 2003; Lee, 2002; Brenner
et al., 2003, Keri et al., 2004; Steve et al., 1997; O’Donnel et al., 1996,
as cited in Butler et al., 2005) reﬂect dorsal visual pathwaymalfunc-
tion, because the dorsal pathway receives initial information from
the Magnocellular pathway, Deﬁcits in Magnocellular performance
may also affect higher level malfunction of dorsal visual pathway.
Since all patients were taking antipsychotic medications, the re-
sults of this study are not able to exclude the effect of medications
on the performance of patients with schizophrenia in frequency
doubling test. Several previous studies on visual processing (Brody
et al., 1980; Braff & Saccuzzo, 1982; Harvey et al., 1990; as cited in
Martinez et al., 2008; Butler et al., 1996, 2003; Kadenhed et al.,
1997; Harvey et al., 1990, as cited in Butler et al., 2005), contrast
sensitivity (O’Donnel et al., 2006), motion-processing (Chen et al.,
1999, as cited in Kim et al., 2006), and backward masking deﬁcits
in patients with schizophrenia were not related to antipsychotics.
For example, Butler et al.’s study (1996, 2002; as cited in Schechter
et al., 2003) and a study by Keri et al. (2005) showed that patients
with schizophrenia (both with and without medication) invariably
show deﬁcits in low contrast situations and doubled frequency.
Thus, while antipsychotics are an important issue, there is little
evidence to support this notion. However, future studies should
examine patients at early stages of schizophrenia or those who
are genetically vulnerable to schizophrenia.
N. Khosravani, M.A. Goodarzi / Vision Research 93 (2013) 49–53 53In general, the results from the current study provide good evi-
dence for magno system involvement in schizophrenia. While we
suspect that visual deﬁcitsmay play a causal role in some of the def-
icits caused by the disease (i.e. cognitive deﬁcits), we note that
schizophrenicperceptualdifﬁculties are clearlynot limited tovision.
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